138 related articles for article (PubMed ID: 35738614)
1. The Role of PPAR-gamma C161T Polymorphism in Colorectal Cancer Susceptibility.
Kurnaz-Gomleksiz O; Torun BC; Isbir T; Bulut T; Sokucu N; Yilmaz-Aydogan H; Canbay E
In Vivo; 2022; 36(4):1911-1915. PubMed ID: 35738614
[TBL] [Abstract][Full Text] [Related]
2. The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart disease.
Ding S; Liu L; Zhuge QC; Yu Z; Zhang X; Xie J; Hong W; Wang S; Yang Y; Chen B
Wien Klin Wochenschr; 2012 Oct; 124(19-20):671-7. PubMed ID: 22987045
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case-Control Study.
Unal E; Aslan EI; Ozturk T; Kurnaz Gomleksiz O; Kucukhuseyin O; Tuzuner MB; Seyhan MF; Ozturk O; Yilmaz Aydogan H
Biochem Genet; 2021 Dec; 59(6):1413-1426. PubMed ID: 33893920
[TBL] [Abstract][Full Text] [Related]
4. PPARG gene C161T CT/TT associated with lower blood lipid levels and ischemic stroke from large-artery atherosclerosis in a Han population in Guangdong.
Wei WM; Wu XY; Li ST; Shen Q
Neurol Res; 2016 Jul; 38(7):620-4. PubMed ID: 27264718
[TBL] [Abstract][Full Text] [Related]
5. Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population.
Jiang J; Gajalakshmi V; Wang J; Kuriki K; Suzuki S; Nakamura S; Akasaka S; Ishikawa H; Tokudome S
Cancer Sci; 2005 Aug; 96(8):507-12. PubMed ID: 16108832
[TBL] [Abstract][Full Text] [Related]
6. PPARγ Pro12Ala and C161T polymorphisms in patients with acne vulgaris: Contribution to lipid and lipoprotein profile.
Saeidi S; Chamaie-Nejad F; Ebrahimi A; Najafi F; Rahimi Z; Vaisi-Raygani A; Shakiba E; Rahimi Z
Adv Med Sci; 2018 Mar; 63(1):147-151. PubMed ID: 29120856
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
Szeto CC; Chow KM; Poon PY; Kwan BC; Li PK
Am J Nephrol; 2008; 28(5):715-22. PubMed ID: 18417957
[TBL] [Abstract][Full Text] [Related]
8. Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes.
Yilmaz-Aydogan H; Kurnaz O; Kurt O; Akadam-Teker B; Kucukhuseyin O; Tekeli A; Isbir T
Mol Cell Biochem; 2011 Dec; 358(1-2):355-63. PubMed ID: 21833536
[TBL] [Abstract][Full Text] [Related]
9. [Correlation between polymorphism in the promoter of DNA methyltransferase-3B and the risk of colorectal cancer].
Bao Q; He BS; Chen LP; Gu L; Nie ZL; Wang SK
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Jan; 46(1):53-7. PubMed ID: 22490141
[TBL] [Abstract][Full Text] [Related]
10. Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease.
Shrestha UK; Karimi O; Crusius JB; Zhou F; Wang Z; Chen Z; van Bodegraven AA; Xiao J; Morré SA; Wang H; Li J; Xia B
Inflamm Bowel Dis; 2010 Feb; 16(2):312-9. PubMed ID: 19714744
[TBL] [Abstract][Full Text] [Related]
11. Association between peroxisome proliferator-activated receptor-alpha, delta, and gamma polymorphisms and risk of coronary heart disease: A case-control study and meta-analysis.
Qian Y; Li P; Zhang J; Shi Y; Chen K; Yang J; Wu Y; Ye X
Medicine (Baltimore); 2016 Aug; 95(32):e4299. PubMed ID: 27512842
[TBL] [Abstract][Full Text] [Related]
12. PPARgamma polymorphisms and cancer risk: a meta-analysis involving 32,138 subjects.
Xu W; Li Y; Wang X; Chen B; Liu S; Wang Y; Zhao W; Wu J
Oncol Rep; 2010 Aug; 24(2):579-85. PubMed ID: 20596649
[TBL] [Abstract][Full Text] [Related]
13. Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes.
Yilmaz-Aydogan H; Kurnaz O; Kucukhuseyin O; Akadam-Teker B; Kurt O; Eronat AP; Tekeli A; Bugra Z; Ozturk O
Gene; 2013 Jul; 523(1):20-6. PubMed ID: 23583468
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis.
Lu YL; Li GL; Huang HL; Zhong J; Dai LC
World J Gastroenterol; 2010 May; 16(17):2170-5. PubMed ID: 20440859
[TBL] [Abstract][Full Text] [Related]
15. Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people.
Hui Y; Yu-Yuan L; Yu-Qiang N; Wei-Hong S; Yan-Lei D; Xiao-Bo L; Yong-Jian Z
Liver Int; 2008 Mar; 28(3):385-92. PubMed ID: 17999673
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma C161T polymorphisms and survival of Japanese patients with immunoglobulin A nephropathy.
Song J; Sakatsume M; Narita I; Goto S; Omori K; Takada T; Saito N; Ueno M; Gejyo F
Clin Genet; 2003 Nov; 64(5):398-403. PubMed ID: 14616762
[TBL] [Abstract][Full Text] [Related]
17.
Lin J; Chen Y; Tang WF; Liu C; Zhang S; Guo ZQ; Chen G; Zheng XW
Front Oncol; 2019; 9():63. PubMed ID: 30838172
[No Abstract] [Full Text] [Related]
18. Contribution of Genetic Polymorphisms of Inflammation Response Genes on Sporadic Colorectal Cancer Predisposition Risk in Malaysian Patients - A Case Control Study.
Ankathil R; Mustapha MA; Abdul Aziz AA; Mohd Shahpudin SN; Zakaria AD; Abu Hassan MR; Musa KI
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1621-1632. PubMed ID: 31244280
[TBL] [Abstract][Full Text] [Related]
19. Association of peroxisome proliferator-activated receptorγ gene Pro12Ala and C161T polymorphisms with cardiovascular risk factors in maintenance hemodialysis patients.
Liu F; Mei X; Zhang Y; Qi H; Wang J; Wang Y; Jiang W; Zhang X; Yan H; Zhuang S
Mol Biol Rep; 2014 Nov; 41(11):7555-65. PubMed ID: 25096510
[TBL] [Abstract][Full Text] [Related]
20. Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study.
Penyige A; Poliska S; Csanky E; Scholtz B; Dezso B; Schmelczer I; Kilty I; Takacs L; Nagy L
BMC Med Genet; 2010 Nov; 11():152. PubMed ID: 21044285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
